[1]
Rodrigues, G. et al. 2013. Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer. Canadian Urological Association Journal. 7, 5-6 (Jun. 2013), e411–6. DOI:https://doi.org/10.5489/cuaj.478.